K Number
K160569
Device Name
NeuGuide
Date Cleared
2016-07-06

(128 days)

Product Code
Regulation Number
884.4530
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

NeuGuide is indicated for attaching sutures to ligaments of the pelvic floor.

Device Description

The NeuGuide™ device is indicated for anchoring sutures to ligaments of the pelvic floor. It is a single use instrument, supplied sterile and pre-loaded. The NeuGuide device comprises three elements, the anchor-suture unit, an applicator, and a thimble with work channel.

AI/ML Overview

The provided text describes the NeuGuide device, specifically its indications for use, comparison to a predicate device, and performance data. However, it does not include detailed "acceptance criteria" for performance metrics like accuracy, sensitivity, or specificity, nor does it provide a "study that proves the device meets the acceptance criteria" in the context of typical AI/software device studies.

Instead, the document focuses on the mechanical, material, and functional characteristics of the NeuGuide device itself, along with general performance tests to confirm its safety and fundamental functionality compared to a predicate device.

Given this, I will extract and infer information from the provided text to best answer your request, focusing on the available performance data described.

Here's the breakdown of the information that can be extracted or reasonably inferred from the document:

1. Table of Acceptance Criteria and Reported Device Performance

The acceptance criteria provided are essentially a "pass" or "fail" for various engineering and biocompatibility tests. No specific numerical thresholds are given in the summary, just the conclusion of "Pass according to predefined acceptance criteria."

Test CategorySpecific TestAcceptance Criteria (Stated)Reported Device Performance
BiocompatibilityCytotoxicityPassed ISO 10993-1, 5, 6, 10, 11, 18Demonstrated biocompatible
Intracutaneous reactivityPassed ISO 10993-1, 5, 6, 10, 11, 18Demonstrated biocompatible
SensitizationPassed ISO 10993-1, 5, 6, 10, 11, 18Demonstrated biocompatible
ImplantationPassed ISO 10993-1, 5, 6, 10, 11, 18Demonstrated biocompatible
Acute systemic toxicityPassed ISO 10993-1, 5, 6, 10, 11, 18Demonstrated biocompatible
Extractable and Leachable testingPassed ISO 10993-1, 5, 6, 10, 11, 18Demonstrated biocompatible
CorrosionAnchor - Cyclic potentiodynamic polarizationPassed ASTM F2129Passed
Applicator - Boil testPassed ASTM F1089Passed
Applicator - Copper sulfate corrosion testPassed ASTM F1089Passed
Suture TestingAnchor to suture attachment forceUSP 37-NF32 standardsPassed
Suture diameterUSP 37-NF32 <881> standardsPassed
Suture tearing forceUSP 37-NF32 <861> standardsPassed
Anchor Strength & FixationAnchor spurs shear forcePredefined acceptance criteriaPassed
Anchor deploymentPredefined acceptance criteriaPassed
Anchor pull-out force (porcine ligament in situ)Predefined acceptance criteriaPassed
Functional TestingEntire system functionalityPredefined acceptance criteriaPassed
MRI CompatibilityMagnetic field interactionsMR Conditional labelingDemonstrated MR Conditional
MR related heatingMR Conditional labelingDemonstrated MR Conditional
Artifact testMR Conditional labelingDemonstrated MR Conditional
Sterilization ValidationETO validation to SAL 10-6Predefined acceptance criteriaPassed
LAL endotoxin pyrogenicityPredefined acceptance criteriaPassed
ETO residual levelsPredefined acceptance criteriaPassed
Packaging ValidationSterile barrier validation (To and after 1 year)Supports 1 year shelf lifeSupports 1 year shelf life
Shelf Life ValidationFunctional validation of product (after 1 year)Supports 1 year shelf lifeSupports 1 year shelf life
Transportation ValidationFunctional testing after transportationPredefined acceptance criteriaPassed

2. Sample Size Used for the Test Set and Data Provenance

  • Sample Size: Not explicitly stated for most tests. For "Anchor pull-out force in porcine ligament in situ," the sample is "porcine ligament in situ," which implies an ex vivo or in vivo animal model, but the number of samples is not given.
  • Data Provenance: The tests are largely laboratory-based performance tests for a medical device (NeuGuide) developed by Pop Medical Solutions Ltd. in Israel. The document does not specify country of origin for test data beyond the company's location. The testing appears to be prospective with respect to the device's design confirmation.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

This information is not applicable to the studies described. The "ground truth" here is determined by engineering standards (e.g., ASTM, ISO, USP) and the physical properties of the device materials and mechanics, not by expert interpretation of medical images or clinical data.

4. Adjudication Method for the Test Set

Not applicable. The tests are based on objective measurements and compliance with established standards, not expert adjudication of subjective assessments.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This is a manual surgical instrument, not an AI or imaging diagnostic device that would involve human readers.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

Not applicable. This device is a manual instrument, not an algorithm or AI system. Its performance is always human-in-the-loop (the surgeon). The studies focus on the intrinsic properties and functionality of the device itself.

7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.)

The ground truth for the various tests described is based on established engineering standards, material science specifications, and validated laboratory methodologies. For example:

  • Biocompatibility: ISO 10993 standards.
  • Corrosion: ASTM F2129, ASTM F1089.
  • Suture testing: USP 37-NF32 standards.
  • MRI Compatibility: Standards for MR Conditional labeling.
  • Sterilization: ETO validation to SAL 10-6.

For functional tests like "Anchor pull-out force," the "ground truth" would be the measured physical force required for pull-out, compared against a predefined engineering specification.

8. The Sample Size for the Training Set

Not applicable. This is a mechanical device, not a machine learning model, so there is no "training set."

9. How the Ground Truth for the Training Set Was Established

Not applicable, as there is no training set for this type of device.

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image is a seal for the Department of Health & Human Services - USA. The seal is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an image of three stylized human profiles facing to the right. The profiles are stacked on top of each other, with the top profile being the largest and the bottom profile being the smallest.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

July 6, 2016

POP Medical Solutions Paul Dryden Regulatory Consultant 27 Habarzel St. Tel Aviv. 6971039 IL

Re: K160569 Trade/Device Name: NeuGuide Regulation Number: 21 CFR 884.4530 Regulation Name: Obstetric-Gynecologic Specialized Manual Instrument Regulatory Class: Class II Product Code: PBQ Dated: June 10, 2016 Received: June 13, 2016

Dear Paul Dryden,

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

{1}------------------------------------------------

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Benjamin R. Fisher -S

Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K160569

Device Name NeuGuide

Indications for Use (Describe)

NeuGuide is indicated for attaching sutures to ligaments of the pelvic floor.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image contains the logo for POP Medical Solutions. The logo features the letters "POP" stacked on top of each other in a stylized, blue font. Below the logo, the words "Medical Solutions" are written in a smaller, sans-serif font. Underneath that, the words "POP NeuGuide" are written in a larger, sans-serif font.

510(k) summary

1.Submitter
Submitted by:Pop Medical Solutions Ltd.
Habarzel St. 27, Tel Aviv 6971039, Israel
Phone: +972-3- 7684948
Fax: +972-3- 7684941
Official contact:Guy Ohad, CEO
Date prepared:10-June-2016
2.Device
Trade name:NeuGuide
Common name:Pelvic ligament fixation system
Regulation/21 CFR 884.4530 - Obstetric-gynecologic specialized manual instrument
Classification name:
Product Code:PBQ - Fixation, non-absorbable or absorbable, for pelvic use
Regulatory class:II
3.Predicate device
Predicate device:K120831 Neomedic Anchorsure

4. Device description

The NeuGuide™ device is indicated for anchoring sutures to ligaments of the pelvic floor. It is a single use instrument, supplied sterile and pre-loaded. The NeuGuide device comprises three elements, the anchor-suture unit, an applicator, and a thimble with work channel.

ComponentCharacteristicsMaterial
AnchorDiameter 2.0 mmLength 9.0 mmNitinol
SutureUSP 0Diameter 0.4 mmLength 740 mmPolypropylene monofilament
Applicator ShaftDiameter 2.5 mmLength 284 mmStainless steel AISI 316L
Applicator HandleBase diameter 28mmBody diameter 6 - 14.6mmPOM-C Tecaform AH MT WhitePolycarbonate
ThimbleWorking channel innerdiameter 2.6 mmDSM Somos WaterShedXC 11122

{4}------------------------------------------------

Image /page/4/Picture/1 description: The image shows the logo for POP Medical Solutions. The logo features the letters "POP" in a stylized, blue font, with the "O"s stacked on top of the "P". Below the logo, the words "Medical Solutions" are written in a smaller, blue font. Underneath that, the words "POP NeuGuide" are written in a larger, black font.

5. Indications for use

NeuGuide is indicated for attaching sutures to ligaments of the pelvic floor.

6. Comparison with the predicate device

Both the subject and predicate devices are indicated for attaching sutures to ligaments of the pelvic floor.

The basic technological characteristics of the NeuGuide are the same as those of the predicate. Both are:

  • Manual delivery of an anchor-suture implant via applicator handle
  • . Single use, supplied sterile and pre-loaded
  • Fixation in the ligament utilizing a non-absorbable suture tied to an anchor

The main technological differences between the NeuGuide and the predicate include the anchor shape (two deployable spurs on the NeuGuide vs. four stationary barbs on the predicate), anchor material (Nitinol in the NeuGuide vs. PEEK in the predicate), and the use of a thimble with the NeuGuide (no thimble is utilized with the predicate). These differences do not raise new types of safety or effectiveness questions. These differences have been evaluated in performance testing, including MRI compatibility, biocompatibility, corrosion testing, pull out force, and deployment force.

TestDetailsConclusions
BiocompatibilityCytotoxicity, intracutaneousreactivity, sensitization,implantation, acute systemictoxicity, Extractable and Leachabletesting with risk based assessment ofthe findingsNeuGuide was demonstratedto be biocompatible
ISO 10993-1
ISO 10993-5
ISO 10993-6
ISO 10993-10
ISO 10993-11
ISO 10993-18
CorrosionAnchor - cyclic potentiodynamicpolarizationApplicator - Boil test, copper sulfatecorrosion testBoth tests were passedaccording to predefinedacceptance criteria
Anchor - ASTM F2129
Applicator - ASTM F1089
Suture testingAnchor to suture attachment forceSuture diameterSuture tearing forcePass according to predefinedacceptance criteria
USP 37-NF32
USP 37-NF32 <881>
USP 37-NF32 <861>
Anchor strength andfixation forcesAnchor spurs shear forceAnchor deploymentAnchor pull-out force in porcineligament in situPass according to predefinedacceptance criteria
Functional testingTest entire system together forfunctionalityPass according to predefinedacceptance criteria

7. Performance data

The NeuGuide has undergone and successfully passed performance testing as follows:

{5}------------------------------------------------

Image /page/5/Picture/1 description: The image contains a logo for a medical solutions company. The logo features the letters "POP" in a stylized, blue font, with the "O" appearing to be formed by a cloud-like shape. Below the logo, the words "Medical Solutions" are written in a smaller, blue font. Underneath that, the words "POP NeuGuide" are written in a larger, black font.

MRI compatibility- 3 TeslaMagnetic field interactionsThe NeuGuide™ Anchor was
MR related heatingdemonstrated to be MR
Artifact testConditional. A patient with
MR conditional labelingthis device can be scanned
safely, immediately after
placement under conditions
specified in the labeling
Sterilization validationETO validation to SAL 10-6Pass according to predefined
LAL endotoxin pyrogenicityacceptance criteria
ETO residual levels
Packaging validationSterile barrier validation at To andTesting supports 1 year shelf
after 1 year shelf lifelife.
Shelf life validationFunctional validation of productTesting supports 1 year shelf
after 1 year shelf lifelife.
Transportation validationFunctional testing of device afterPass according to predefined
transportationacceptance criteria

8. Conclusions

NeuGuide is substantially equivalent to the predicate device.

§ 884.4530 Obstetric-gynecologic specialized manual instrument.

(a)
Identification. An obstetric-gynecologic specialized manual instrument is one of a group of devices used during obstetric-gynecologic procedures to perform manipulative diagnostic and surgical functions (e.g., dilating, grasping, measuring, and scraping), where structural integrity is the chief criterion of device performance. This type of device consists of the following:(1) An amniotome is an instrument used to rupture the fetal membranes.
(2) A circumcision clamp is an instrument used to compress the foreskin of the penis during circumcision of a male infant.
(3) An umbilical clamp is an instrument used to compress the umbilical cord.
(4) A uterine curette is an instrument used to scrape and remove material from the uterus.
(5) A fixed-size cervical dilator is any of a series of bougies of various sizes used to dilate the cervical os by stretching the cervix.
(6) A uterine elevator is an instrument inserted into the uterus used to lift and manipulate the uterus.
(7) A gynecological surgical forceps is an instrument with two blades and handles used to pull, grasp, or compress during gynecological examination.
(8) A cervical cone knife is a cutting instrument used to excise and remove tissue from the cervix.
(9) A gynecological cerclage needle is a looplike instrument used to suture the cervix.
(10) A hook-type contraceptive intrauterine device (IUD) remover is an instrument used to remove an IUD from the uterus.
(11) A gynecological fibroid screw is an instrument used to hold onto a fibroid.
(12) A uterine sound is an instrument used to determine the depth of the uterus by inserting it into the uterine cavity.
(13) A cytological cervical spatula is a blunt instrument used to scrape and remove cytological material from the surface of the cervix or vagina.
(14) A gynecological biopsy forceps is an instrument with two blades and handles used for gynecological biopsy procedures.
(15) A uterine tenaculum is a hooklike instrument used to seize and hold the cervix or fundus.
(16) An internal pelvimeter is an instrument used within the vagina to measure the diameter and capacity of the pelvis.
(17) A nonmetal vaginal speculum is a nonmetal instrument used to expose the interior of the vagina.
(18) A fiberoptic nonmetal vaginal speculum is a nonmetal instrument, with fiberoptic light, used to expose and illuminate the interior of the vagina.
(b)
Classification. (1) Class II (special controls). The device, when it is an umbilical clamp with or without a cutter, a uterine tenaculum which is sterile and does not use suction and is intended for single use, a nonmetal vaginal speculum, or a fiberoptic nonmetal vaginal speculum, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.(2) Class I for the amniotome, uterine curette, cervical dilator (fixed-size bougies), cerclage needle, IUD remover, uterine sound, and gynecological biopsy forceps. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 884.9.